New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans

Abstract

Our findings provide new evidence for the therapeutic potential of curcumin to treat human NAFLD. However, the development of a preventive treatment targeting human circulating monocytes and liver macrophages as well as peripheral and hepatic CD4+ cells requires additional research.